Antibody-Drug Conjugates 2011 - A Technology, Stakeholder and R&D Pipeline Analysis
This report "Antibody-Drug Conjugates 2011 - real breakthrough still to come: A Technology, Stakeholder and R&D Pipeline Analysis" published in September 2011 provides the most complete compilation of information about antibody-drug conjugate (ADC) companies, technologies and products in R&D. A comprehensive analysis of the state of the art and key trends guides the reader through this complex subject. Stakeholders in the field of antibody-drug conjugates are analysed and their contribution to the growth ADC technology and products is assessed. A...
View full press release